Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...

Cocoa extract supplementation among older adults had no effect overall on the occurrence of age-related macular degeneration ...

GSK's main partner in the consumer health joint venture that became Haleon – Pfizer – holds the remaining 32% in the new company and has said that it will sell its stake now that the ...

A high-touch approach, intellectual vigour and enough creativity to earn the confidence of clients have become the ...

Global IPO markets made steady gains in 2024, with IPO proceeds increasing compared to the previous year as the high interest ...

Haleon said in a prospectus filed earlier this week that it could face "possible liabilities" connected with OTC Zantac, although it is in the midst of indemnity negotiations with GSK and Pfizer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...